Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy

by Ling L., Tan S.K., Goh T.H., Cheung E., VICTOR NURCOMBE, van Wijnen A.J., Cool S.M.
Published 2020